A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients
Clinical trial NCT07644351 · COMPLETED
Trial details
- NCT number
- NCT07644351
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-12-16
- Primary completion
- 2025-09-17
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.